The University of Chicago Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Cohen, Russell D.
Item TypeName
Concept Immunosuppressive Agents
Academic Article A comparison of the quality of life in patients with severe ulcerative colitis after total colectomy versus medical treatment with intravenous cyclosporin.
Academic Article Efficacy of parenteral methotrexate in refractory Crohn's disease.
Academic Article Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial.
Academic Article Evolving medical therapies for ulcerative colitis.
Academic Article Medical therapy for ulcerative colitis: the state of the art and beyond.
Academic Article Managing immunogenic responses to infliximab: treatment implications for patients with Crohn's disease.
Academic Article Medical management of severe ulcerative colitis.
Academic Article What is the optimal maintenance treatment for ulcerative colitis?
Academic Article Methotrexate in IBD--move over 6-MP? Not so fast...
Academic Article Serious infection and mortality in patients with Crohn's disease: more than 5 years of follow-up in the TREATâ„¢ registry.
Academic Article Natalizumab in Crohn's disease: results from a US tertiary inflammatory bowel disease center.
Academic Article Serious infections and mortality in association with therapies for Crohn's disease: TREAT registry.
Academic Article Optimizing conventional therapy for inflammatory bowel disease.
Academic Article Incidence and predictors of clinical response, re-induction dose, and maintenance dose escalation with certolizumab pegol in Crohn's disease.
Academic Article Drug therapies and the risk of malignancy in Crohn's disease: results from the TREATâ„¢ Registry.
Academic Article Prevalence of Antibodies Against JC Virus in Patients With Refractory Crohn's Disease and Effects of Natalizumab Therapy.
Academic Article Infliximab for Crohn's Disease: More Than 13 Years of Real-world Experience.
Academic Article Clinical Response and Complications are not Associated with Drug Levels in Patients with Severe Ulcerative Colitis on IV Cyclosporine Induction Therapy.
Academic Article Ciclosporin Therapy After Infliximab Failure in Hospitalized Patients With Acute Severe Colitis is Effective and Safe.
Academic Article Intravenous cyclosporine in severe ulcerative colitis: ready to stand alone?
Academic Article Risk factors and treatment outcomes of peristomal pyoderma gangrenosum in patients with inflammatory bowel disease.
Search Criteria
  • Immunosuppressive Agents